Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Epoetin beta 3,000units/0.3ml solution for injection pre-filled syringes 6 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Eprex 40,000units/1ml solution for injection vials (Janssen-Cilag Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ascorbic acid 500mg/5ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcitriol 2micrograms/1ml solution for injection ampoules 25 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeoRecormon 3,000units/0.3ml solution for injection pre-filled syringes (Roche Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 1g/10ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcijex 2micrograms/1ml solution for injection ampoules (Abbott Laboratories Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ascorbic acid 500mg/5ml solution for injection ampoules (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 1g/10ml solution for injection vials (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ascorbic acid 500mg/5ml solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 1g/10ml solution for injection vials (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 1g/10ml solution for injection vials (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Flagyl 500mg/100ml solution for injection 100ml bags (Aventis Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Metrozol 500mg/100ml solution for injection 100ml bags (Miza Biopharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Metronidazole 500mg/100ml solution for injection bags (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 5g/200ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 5g/200ml solution for injection vials (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 5g/200ml solution for injection vials (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoetin beta 4,000units/0.3ml solution for injection pre-filled syringes 6 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 5g/200ml solution for injection vials (Goldshield Healthcare Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeoRecormon 4,000units/0.3ml solution for injection pre-filled syringes (Roche Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 200mg/8ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 200mg/8ml solution for injection vials (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 200mg/8ml solution for injection vials (Goldshield Healthcare Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 200mg/8ml solution for injection vials (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoetin beta 5,000units/0.3ml solution for injection pre-filled syringes 6 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeoRecormon 5,000units/0.3ml solution for injection pre-filled syringes (Roche Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 500mg/20ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 500mg/20ml solution for injection vials (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcium chloride 10% solution for injection 10ml pre-filled syringes 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 500mg/20ml solution for injection vials (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcium chloride 10% solution for injection 10ml pre-filled syringes (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 500mg/20ml solution for injection vials (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoetin beta 6,000units/0.3ml solution for injection pre-filled syringes 6 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 500mg/20ml solution for injection vials (Goldshield Healthcare Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Minijet calcium chloride 10% solution for injection 10ml pre-filled syringes (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeoRecormon 6,000units/0.3ml solution for injection pre-filled syringes (Roche Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcium chloride 10% solution for injection 10ml pre-filled syringes (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 1g/40ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 1g/40ml solution for injection vials (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 1g/40ml solution for injection vials (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoetin beta 10,000units/0.6ml solution for injection pre-filled syringes 6 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 1g/40ml solution for injection vials (Goldshield Healthcare Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeoRecormon 10,000units/0.6ml solution for injection pre-filled syringes (Roche Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Co-trimoxazole 80mg/400mg/5ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Co-trimoxazole 80mg/400mg/5ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Co-trimoxazole 80mg/400mg/5ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Co-trimoxazole 80mg/400mg/5ml solution for injection ampoules (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Baclofen 50micrograms/1ml solution for injection ampoules 1 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Septrin for Infusion 80mg/400mg/5ml solution for injection ampoules (GlaxoSmithKline) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lioresal Intrathecal 50micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Co-trimoxazole 80mg/400mg/5ml solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Baclofen 10mg/20ml solution for injection ampoules 1 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lioresal Intrathecal 10mg/20ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Baclofen 10mg/5ml solution for injection ampoules 1 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lioresal Intrathecal 10mg/5ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 1mg/1ml (1 in 1,000) solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 1mg/1ml (1 in 1,000) solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 1mg/1ml (1 in 1,000) solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 1mg/1ml (1 in 1,000) solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Testosterone enantate 250mg/1ml solution for injection ampoules 3 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Testosterone enantate 250mg/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Testosterone enantate 250mg/1ml solution for injection ampoules (Cambridge Laboratories) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Testosterone enantate 250mg/1ml solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dalteparin sodium 5,000units/0.2ml solution for injection pre-filled syringes 10 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fragmin 5,000units/0.2ml solution for injection pre-filled syringes (Pfizer Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Haloperidol decanoate 50mg/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Haldol decanoate 50mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Haloperidol decanoate 100mg/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Haldol decanoate 100mg/1ml solution for injection ampoules (Janssen-Cilag Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 100mg/10ml (1%) solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 100mg/10ml (1%) solution for injection ampoules 20 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 100mg/10ml (1%) solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sure-Amp lidocaine 100mg/10ml (1%) solution for injection ampoules (Antigen Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mini-Plasco lidocaine 100mg/10ml (1%) solution for injection ampoules (B.Braun Medical Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 100mg/10ml (1%) solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 100mg/10ml (1%) solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 200mg/20ml (1%) solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 200mg/20ml (1%) solution for injection ampoules 20 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 200mg/20ml (1%) solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 200mg/20ml (1%) solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 200mg/20ml (1%) solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 400mg/20ml (2%) solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 400mg/20ml (2%) solution for injection ampoules 20 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 400mg/20ml (2%) solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 400mg/20ml (2%) solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Apomorphine 30mg/3ml solution for injection pre-filled disposable devices 5 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
APO-go Pen 30mg/3ml solution for injection (Britannia Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Apomorphine 20mg/2ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
APO-go 20mg/2ml solution for injection ampoules (Britannia Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Apomorphine 50mg/5ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
APO-go 50mg/5ml solution for injection ampoules (Britannia Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Octreotide 100micrograms/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Pipotiazine 50mg/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Piportil Depot 50mg/1ml solution for injection ampoules (JHC Healthcare Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|